Strides Arcolab receives 5th HIV products approval from WHO
New Delhi, July 4 (UNI) Strides Arcolab Ltd today announced that the World Health Organization (WHO) has included its generic fixed dose combination of Anti-HIV drug Lamivudine/Zidovidine in its list of pre-qualified suppliers.
Prior to this approval, the company has four HIV drugs in the WHO pre-qualified list.
An additional three products have been submitted for pre-qualification, which will complete a comprehensive product offering from the company, a statement said.
UNI DKS RA RK1842